I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 3.18 THB -3.64%
Market Cap: 1.9B THB
Have any thoughts about
Inter Pharma PCL?
Write Note
Section:
 

Relative Value

The Relative Value of one IP stock under the Base Case scenario is 4.37 THB. Compared to the current market price of 3.18 THB, Inter Pharma PCL is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IP Relative Value
Base Case
4.37 THB
Undervaluation 27%
Relative Value
Price
I
Worst Case
Base Case
Best Case

Valuation Multiples

1.1
P/S
P/S
Price to Sales
1.1
vs History
91
vs Industry
49
Median 3Y
2.1
Median 5Y
2.3
Industry
1
Forward
0.7
More Details
72.6
P/E
P/E
Price to Earnings
72.6
vs History
9
vs Industry
7
Median 3Y
37.5
Median 5Y
34.3
Industry
16.8
Forward
5.5
More Details
22
P/OCF
P/OCF
Price to OCF
22
vs History
45
vs Industry
17
Median 3Y
27.6
Median 5Y
24.6
Industry
11.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-10
Median 5Y
13.4
Industry
17.6
More Details
1
P/B
P/B
Price to Book Value
1
vs History
87
vs Industry
61
Median 3Y
1.8
Median 5Y
1.9
Industry
1.6
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
83
vs Industry
51
Median 3Y
2
Median 5Y
2.1
Industry
1.2
Forward
0.7
More Details
2.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.8
vs History
79
vs Industry
57
Median 3Y
4.9
Median 5Y
4.9
Industry
3.8
More Details
10.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.6
vs History
61
vs Industry
35
Median 3Y
14.6
Median 5Y
13.8
Industry
10.3
Forward
5.8
More Details
25.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.8
vs History
25
vs Industry
16
Median 3Y
23.1
Median 5Y
22.4
Industry
12.9
Forward
6.3
More Details
21
EV/OCF
EV/OCF
Enterprise Value to OCF
21
vs History
37
vs Industry
18
Median 3Y
26.4
Median 5Y
21.7
Industry
12.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
2
Median 3Y
-14.6
Median 5Y
-12.6
Industry
15.3
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
91
vs Industry
63
Median 3Y
1.5
Median 5Y
2
Industry
1.2
More Details

Multiples Across Competitors

IP Competitors Multiples
Inter Pharma PCL Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
Inter Pharma PCL
SET:IP
1.9B THB 1.1 72.6 10.6 25.8
FR
L'Oreal SA
PAR:OR
181.7B EUR 4.3 28 18.7 22.2
UK
Unilever PLC
LSE:ULVR
114.1B GBP 2.3 20.7 177.4 204
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.8 53.1 36.5 39.8
UK
HALEON PLC
LSE:HLN
34.9B GBP 3.1 28.9 17.2 19.7
DE
Beiersdorf AG
XETRA:BEI
27.8B EUR 2.9 37.6 16 22.9
US
Estee Lauder Companies Inc
NYSE:EL
27B USD 1.7 132.8 13.1 19.9
JP
Kao Corp
TSE:4452
3T JPY 1.9 36 14.3 25.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7.9 -297.8 35.4 37.8
IN
Dabur India Ltd
NSE:DABUR
903.7B INR 7.3 50.5 38.3 46.7
US
Bellring Brands Inc
NYSE:BRBR
9.9B USD 4.9 40.1 25.1 27.4
P/E Multiple
Earnings Growth P/E to Growth
TH
I
Inter Pharma PCL
SET:IP
Average P/E: 50
72.6
N/A N/A
FR
L'Oreal SA
PAR:OR
28
30%
0.9
UK
Unilever PLC
LSE:ULVR
20.7
25%
0.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
53.1
32%
1.6
UK
HALEON PLC
LSE:HLN
28.9
-7%
N/A
DE
Beiersdorf AG
XETRA:BEI
37.6
61%
0.6
US
Estee Lauder Companies Inc
NYSE:EL
132.8
245%
0.5
JP
Kao Corp
TSE:4452
36
205%
0.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -297.8 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
50.5
39%
1.3
US
Bellring Brands Inc
NYSE:BRBR
40.1
56%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TH
I
Inter Pharma PCL
SET:IP
Average EV/EBITDA: 36.6
10.6
N/A N/A
FR
L'Oreal SA
PAR:OR
18.7
28%
0.7
UK
Unilever PLC
LSE:ULVR
177.4
20%
8.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.5
29%
1.2
UK
HALEON PLC
LSE:HLN
17.2
13%
1.3
DE
Beiersdorf AG
XETRA:BEI
16
11%
1.4
US
Estee Lauder Companies Inc
NYSE:EL
13.1
26%
0.5
JP
Kao Corp
TSE:4452
14.3
55%
0.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
35.4
41%
0.9
IN
Dabur India Ltd
NSE:DABUR
38.3
35%
1.1
US
Bellring Brands Inc
NYSE:BRBR
25.1
47%
0.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TH
I
Inter Pharma PCL
SET:IP
Average EV/EBIT: 44.7
25.8
N/A N/A
FR
L'Oreal SA
PAR:OR
22.2
34%
0.7
UK
Unilever PLC
LSE:ULVR
204
22%
9.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.8
31%
1.3
UK
HALEON PLC
LSE:HLN
19.7
13%
1.5
DE
Beiersdorf AG
XETRA:BEI
22.9
21%
1.1
US
Estee Lauder Companies Inc
NYSE:EL
19.9
35%
0.6
JP
Kao Corp
TSE:4452
25.8
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
37.8
44%
0.9
IN
Dabur India Ltd
NSE:DABUR
46.7
37%
1.3
US
Bellring Brands Inc
NYSE:BRBR
27.4
48%
0.6

See Also

Summary
IP intrinsic value, competitors valuation, and company profile.
DCF Valuation
IP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IP stock valuation using valuation multiples.
Wall Street Estimates
IP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.